54gene secures $25m funding to advance drug discovery in Africa
54gene, a Nigerian health tech company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round. The round was led by Cathay AfricInvest Innovation Fund with participation from Adjuvant Capital, KdT Ventures, Plexo Capital, Endeavor Capital, Ingressive Capital and others. In April of 2020, the biotech startup closed…

